Top

Reactions Weekly

Published in:

01-11-2022 | Electroconvulsive Therapy | Case report

Paliperidone

Neuroleptic malignant syndrome: case report

Published in: Reactions Weekly | Issue 1/2022

Excerpt

Author Information

An event is serious (based on the ICH definition) when the patient outcome is&colon;

* death
* life-threatening
* hospitalisation
* disability
* congenital anomaly
* other medically important event

…

In the opening statement of the abstract, the patient was addressed as female. However, in the later part of the abstract, the patient was addressed as male (he, his). For this report, we have considered patient's gender as female.

Gultekin M, et al. Paliperidone Induced Neuroleptic Malignant Syndrome Treated with Electroconvulsive Therapy and Continuous Apomorphine: A Case Report. Movement Disorders 37 (Suppl. 2): S250 abstr. 503, Sep 2022. Available from: URL: http://doi.org/10.1002/mds.29223 [abstract]

Title: Paliperidone
Neuroleptic malignant syndrome: case report
Publication date: 01-11-2022
Publisher: Springer International Publishing
Keywords: Electroconvulsive Therapy
Bipolar Disorders
Paliperidone
Bromocriptine
Apomorphine
Amantadine
Biperiden
Lorazepam
Published in: Reactions Weekly / Issue 1/2022
Print ISSN: 0114-9954
Electronic ISSN: 1179-2051
DOI: https://doi.org/10.1007/s40278-022-27851-6

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Paliperidone

Neuroleptic malignant syndrome: case report

Excerpt

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 1/2022

Doxycycline

Multiple drugs

Dinutuximab-beta/nivolumab

Capmatinib/tepotinib

Doxorubicin

Methyldopa/nicardipine